The burgeoning field of metabolic management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These groundbreaking therapies represent a https://neveezun870961.wikinewspaper.com/4289177/glp_3_receptor_agonists_retatrutide_trizepatide